Cartesian Therapeutics
Earnings Surprise
Analysts estimated RNAC earnings of $-0.87 per share this quarter (Q4). RNAC's actual earnings were $-3.57 per share.
RNAC EPS surprise of -310.16%Analysts estimated RNAC earnings of $-0.86 per share this quarter (Q3). RNAC's actual earnings were $-1.38 per share.
RNAC EPS surprise of -60.11%Analysts estimated RNAC earnings of $-0.83 per share this quarter (Q2). RNAC's actual earnings were $0.50 per share.
RNAC EPS surprise of 160.52%Analysts estimated RNAC earnings of $-0.72 per share this quarter (Q1). RNAC's actual earnings were $-0.68 per share.
RNAC EPS surprise of 5.53%Analysts estimated RNAC earnings of $-0.82 per share this quarter (Q4). RNAC's actual earnings were $-0.59 per share.
RNAC EPS surprise of 27.70%Analysts estimated RNAC earnings of $-0.81 per share this quarter (Q3). RNAC's actual earnings were $-1.13 per share.
RNAC EPS surprise of -39.89%Analysts estimated RNAC earnings of $-1.09 per share this quarter (Q2). RNAC's actual earnings were $0.54 per share.
RNAC EPS surprise of 149.63%Analysts estimated RNAC earnings of $-0.90 per share this quarter (Q1). RNAC's actual earnings were $-10.50 per share.
RNAC EPS surprise of -1063.18%Analysts estimated RNAC earnings of $-1.07 per share this quarter (Q4). RNAC's actual earnings were $-2.10 per share.
RNAC EPS surprise of 96.08%Analysts estimated RNAC earnings of $-0.06 per share this quarter (Q3). RNAC's actual earnings were $-0.06 per share.
RNAC EPS surprise of 0.84%